MKLNF Financial Statements From 2010 to 2025
| MKLNF Stock | USD 11.73 0.00 0.00% |
Check M1 Kliniken financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among M1 Kliniken's main balance sheet or income statement drivers, such as , as well as many indicators such as . MKLNF financial statements analysis is a perfect complement when working with M1 Kliniken Valuation or Volatility modules.
MKLNF |
M1 Kliniken AG Company Return On Asset Analysis
M1 Kliniken's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current M1 Kliniken Return On Asset | 0.0309 |
Most of M1 Kliniken's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, M1 Kliniken AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, M1 Kliniken AG has a Return On Asset of 0.0309. This is 100.35% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The return on asset for all United States stocks is 122.07% lower than that of the firm.
M1 Kliniken AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining M1 Kliniken's current stock value. Our valuation model uses many indicators to compare M1 Kliniken value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across M1 Kliniken competition to find correlations between indicators driving M1 Kliniken's intrinsic value. More Info.M1 Kliniken AG is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for M1 Kliniken AG is roughly 1.88 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the M1 Kliniken's earnings, one of the primary drivers of an investment's value.About M1 Kliniken Financial Statements
M1 Kliniken stakeholders use historical fundamental indicators, such as M1 Kliniken's revenue or net income, to determine how well the company is positioned to perform in the future. Although M1 Kliniken investors may analyze each financial statement separately, they are all interrelated. For example, changes in M1 Kliniken's assets and liabilities are reflected in the revenues and expenses on M1 Kliniken's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in M1 Kliniken AG. Please read more on our technical analysis and fundamental analysis pages.
M1 Kliniken AG, together with its subsidiaries, operates medical centers for aesthetic medicine and plastic surgery in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, and Australia. M1 Kliniken AG was founded in 2007 and is based in Berlin, Germany. M1 Kliniken operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 428 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in MKLNF Pink Sheet
M1 Kliniken financial ratios help investors to determine whether MKLNF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in MKLNF with respect to the benefits of owning M1 Kliniken security.